Defects in lysosomal trafficking pathways lead to decreased cell viability and are associated with progressive disorders in humans. Previously we have found that loss-of-function mutations (LOF) in the Drosophila gene blue cheese (bchs) leads to reduced adult lifespan, increased neuronal death and widespread CNS degeneration that is associated with the formation of ubiquitinated-protein aggregates. To identify potential genes that participate in the bchs functional pathway, we conducted a genetic modifier screen based on alterations of an eye phenotype that arises from highlevel overexpression of Bchs. We found that mutations in select autophagic and endocytic trafficking genes, defects in cytoskeletal and motor proteins as well as mutations in the SUMO and ubiquitin signaling pathways behave as modifiers of the Bchs gain-of-function (GOF) eye phenotype. Individual mutant alleles that produced viable adults were further examined for bchslike phenotypes. Mutations in several lysosomal trafficking genes resulted in significantly decreased adult lifespans and several mutants showed changes in ubiquitinated protein profiles as young adults. This work represents a novel approach to examine the role that lysosomal transport and function has on adult viability. The genes characterized in this study have direct human homologues, suggesting that similar defects in lysosomal transport may play a role in human health and age-related processes.
INTRODUCTION
Lysosomes are critical organelles for the turnover or degradation of a wide variety of cellular constituents (DELL'ANGELICA et al. 2000) . A complex series of targeting and import pathways direct the flow of material to the lysosome and defects in these pathways are associated with many progressive conditions including lysosomal storage disorders, reduced viability and neural degeneration (BRUNK and TERMAN 2002; CATALDO et al. 1996; CUERVO 2004; DELL'ANGELICA et al. 2000) . There are three main vesicle-based pathways for transport of material to the lysosome; transport from the trans-Golgi network (TGN), the endocytotic pathway and macroautophagy (here after called autophagy) (KLIONSKY et al. 2003; LUZIO et al. 2005; RAIBORG et al. 2003; SHIH et al. 2002) . Autophagy involves the sequestration of cytoplasmic material and entire organelles into double membrane vesicles called autophagosomes, which are transported along microtubules for fusion with lysosomes, generating autolysosomes where the sequestered material is degraded (KLIONSKY and EMR 2000) . Groundbreaking genetic studies in yeast have allowed the identification and characterization of nearly 30-conserved autophagy (atg) genes (KLIONSKY et al. 2003) . Inactivation of key components within the pathway has revealed that autophagy primarily functions as an adaptive response to starvation or cellular stress by recycling non-essential cellular components for nutrition or by clearing old or damaged cytoplasmic material and organelles (KOMATSU et al. 2005; SCOTT et al. 2004) . Recent genetic studies in mice have shown that ablation of the atg5 and atg7 genes in the CNS leads to progressive neurological defects, the formation of ubiquitinated inclusion bodies or protein aggregates and neuronal cell death (HARA et al. 2006; KOMATSU et al. 2006) .
Previously we have shown that mutations in the Drosophila blue cheese gene (bchs) results in a reduced adult lifespan and age-related neuronal degeneration. These defects include neural atrophy and cell death, preceded by the accumulation of ubiquitin-conjugated protein aggregates throughout the adult CNS (FINLEY et al. 2003) . Consistent with these findings is the recent characterization of Alfy (Autophagy linked FYVE protein) the conserved human bchs homologue ( Figure 1a ) (SIMONSEN et al. 2004 ). Under starvation conditions or following proteasome inhibitor treatment Alfy relocalizes from the nuclear membrane to cytoplasmic structures containing ubiquitin and early autophagic markers (SIMONSEN et al. 2004) . Both Bchs and Alfy proteins are very large, highly conserved proteins that are nearly 400 kDa in size (≈ 50% identity between fly and human homologues) (FINLEY et al. 2003; SIMONSEN et al. 2004) . Both proteins contain several conserved protein domains in the C-terminus; a BEACH domain followed by a series of WD40 repeats and a PI(3)P-binding FYVE domain ( Figure 1a ) (FINLEY et al. 2003; SIMONSEN et al. 2004) . The N-terminal two-thirds of Bchs/Alfy (over 2000 amino acids) are also conserved, but do not contain readily identifiable functional domains. However, this region is leucine/isoleucine rich and modeling programs suggest the presence of leucine zippers and coiled-coil domains. Based on this sequence analysis it's likely that Bchs/Alfy serve as scaffolding proteins, mediating a diverse series of protein and lipid interactions promoting the recruitment, organization and transport of vesicles. Taken together, this information suggests that the Bcsh/Alfy family aids in the removal of cytoplasmic ubiquitinated protein aggregates by promoting their autophagic clearance (BJORKOY et al. 2005) . This protein family is not found in yeast and the Bchs/Alfy proteins may have a greater role in multi-cellular organisms in protein clearance than in starvation-induced autophagy (FINLEY et al. 2003; SIMONSEN et al. 2004) . However, the cellular pathway(s) that Bchs participates in remains poorly understood.
A recent study showed that overexpression of Bchs in the eye using a GMR-Gal4 driver results in a rough eye phenotype (KHODOSH et al. 2006) . Using a genetic modifier screen, 195 chromosomal deficiencies lines were crossed to the Bchs overexpressing line and individual genes uncovered by a single deletion (93B6-7; 93D2) were examined further for Bchs interaction (KHODOSH et al. 2006) . Individual rab11 mutations were found to significantly enhance the dominant Bchs eye phenotype and additional studies revealed that the Rab11 and Bchs proteins colocalize at the neuromuscular junction and affect bristle development and synaptic function (KHODOSH et al. 2006) . In this report, we show that overexpressing Bchs in the eye (GMR-Gal4 driver) also results in a rough eye phenotype that is accompanied by the formation of ubiquitin containing varicosities along photoreceptor neural projections. This phenotype is also seen when Bchs is overexpressed in larval motor neurons and is similar to defects associated with perturbations of vesicle transport or fusion pathways (GUNAWARDENA and GOLDSTEIN 2001; KRAUT et al. 2001; NIXON et al. 2005; TORROJA et al. 1999) . We further show that young bchs mutants and flies overexpressing Bchs display an altered accumulation profile of ubiquitinated proteins (UBproteins). Collectively, these findings suggest that Bchs affects protein and vesicle trafficking and is consistent with its role in the transport of lysosomal substrates. To further investigate potential bchs genetic interactions an extensive genetic screen based on alteration of the Bchs eye phenotype was used to identify several unique modifier loci (FLYBASE. BIO.INDIANA.EDU 2007) . From this study recessive mutations in lysosomal trafficking genes, cytoskeletal and motor proteins as well as members of the ubiquitin and SUMO signaling pathways were found to have potential genetic interactions with Bchs (FLYBASE. BIO.INDIANA.EDU 2007) .
To further characterize mutant phenotypes, mutations in lysosomal genes that produced viable adult flies were examined for UBprotein profiles and changes to adult longevity. As with bchs mutants, the functional losses of several lysosomal transport genes also alter high-molecular weight UB-protein profiles and reduce adult longevity. Together the genetic analysis of several lysosomal trafficking genes provides a novel mechanistic insight into the requirement of these pathways for the long-term viability of adult Drosophila.
MATERIALS AND METHODS
Protein sequence analysis and motifs: Identification and characterization of potential functional domains encoded within the Bchs and Alfy protein sequences were performed using online modeling algorithms including scansite.mit.edu/motifsca, ncbi.nlm.nih.gov/Structure and scansite.mit.edu.
Fly culture and stocks: Flies were cultured and maintained on standard cornmeal-molassesyeast based medium. The transgenic line, EP(2L)2299 was originally from the Rörth collection of P-element insertions and allows Gal4-driven expression of the full-length Bchs protein (KRAUT et al. 2001; RORTH 1996) . The bcsh 5 allele and revertant lines that were derived from excision of the EP(2L)2299 P-element are described previously and outlined in Figure 1b (FINLEY et al. 2003) . The bchs P-element insertion allele, bcsh 3 was maintained as a stock over the Df(2L)clot7 chromosome (402-11Cy/Df(2L)clot7) and used for aging and starvation studies (FINLEY et al. 2003; FLYBASE.BIO.INDIANA.EDU 2007) . Drosophila stocks screened in this study were primarily obtained from the Bloomington Stock Center (stock numbers are noted in Figure 2 and (KRAMER and PHISTRY 1999) and the UAS-GFP-CAAX (membrane-targeted GFP) and GMR-Gal4 transgenic lines have been described previously (FINLEY et al. 1998) .
Western analysis of the Bchs protein and ubiquitinated conjugated proteins: Groups of 50 fly heads per genotype were collected and homogenized in 1x PBS, 0.1% Triton-X buffer containing protease inhibitors (4°C). After centrifugation the supernatants were collected for each genotype and saved as the protein concentrations were determined for each sample using a Lowry assay (BioRad, Hercules, CA). 20 µg of total protein for each sample was loaded and resolved on 4-20% gradient gels (Bio-Rad, Hercules, CA) and electroblotted. Western blots were probed sequentially with anti-Bchs (1:4000 dilution, polyclonal rabbit, a gift from Dr. Kia Zinn, Division of Biology, California Institute of Technology, Pasadena, CA) or anti-Actin antibodies (1:200 dilution, mouse monoclonal JLA20, developed by Jim Jung-Ching Lin and obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biological Sciences, Iowa City, IA 52242). For Western analysis of ubiquitinated proteins, six heads for each genotype (1-day-old flies) were collected and sonicated in 100 µl protein lysis buffer (2% SDS) and centrifuged. 25 µl of each sample were run on a 4-20% gradient gel and Western blots were probed sequentially with anti-Ubiquitin (1:1000 dilution, Cell Signaling), anti-Actin and anti-Bchs antibodies. Following hybridization with appropriate secondary antibodies, immunoreactive bands were detected using standard ECL reagents. Autoradiographs were digitally scanned using a GS-800 Calibrated Desitometer and ImageQuant imaging software and the relative amount of Bchs protein for a given genotype was corrected using actin as a loading control.
Fluorescence confocal microscopy: Staged third instar larvae and pupae from the UAS-GFP-CAAX,GMR-Gal4 stock line or from the UAS-GFP-CAAX,GMR-Gal4/ EP(2)2299 cross were dissected, fixed in 3.5% paraformaldehyde, PBS and rinsed in PBT (0.05% Triton-X). Tissues were mounted and assayed directly for GFP expression patterns or used for co-staining with anti-Bchs or anti-ubiquitin antibodies. For co-staining, tissues were fixed in 3.5% paraformaldehyde, PBS for 1 hour at 4°C and washed three times in PBT (0.05% Triton-X) at 4°C. Following three washes in PBT, tissues were incubated in 5% normal goat serum, PBT and anti-Bchs (1:1000 dilution, Dr. Kia Zinn, Caltech) or with anti-ubiquitin antibodies (1:200 dilution, mouse monoclonal, Cell Signaling) for two hours at room temperature, washed three times and then incubated for one hour at room temperature with Cy3-conjugated anti-rabbit or anti-mouse secondary antibodies (1:200 dilution, Jackson Lab). Tissues were washed three times in PBT and mounted. Images were collected using a Leica TCS SP2 AOBS confocal microscope.
Design of the Bchs gain-of-function modifier screen:
A Bchs based GOF screen was made possible by a characterization fly line containing an EP-UAS modular expression transposable element insertion, EP(2L)2299, which is located upstream of the bchs coding sequence (RORTH 1996) . Previous work reported that this UAS-P-element allowed overexpression of full-length Bchs protein in motor neurons and generated a dominant gain-of-function phenotype (KRAUT et al. 2001) . Overexpressing Bchs in the eye using the GMR-Gal4 driver also produces a highly reproducible dominant phenotype. The GOF phenotype is sensitive to Bchs dosage as shown in flies containing an addition copy of EP(2L)2299 or two copies of both transgenes (Figure 2a) Lifespan analysis: Before analyzing mutant lines for changes in adult lifespan, each stock was first out crossed into a Canton-S or w 1118 background for several generations before reestablishing individual homozygous lines. During the outcrossing process individual mutant lines were assayed for lifespan and multiple experiments pooled. For aging analysis at least 100 newly emerged male flies were collecting for a given genotype and kept on standard Drosophila culture media (25 per vile) (FINLEY et al. 2003) . Flies were placed at 25°C or 29°C with a 12 hour lightdark cycle, turned onto fresh food every two to three days and the number of dead flies counted. The percent of flies remaining alive for a given time point was calculated from the total starting number of flies aged for a particular genotype. The mean genotype lifespan and standard deviation were determined using Microsoft Excel and the P values using GraphPad online software (www.graphpad.com).
RESULTS

Characterization of the bchs EP(2L)2299 P-element and Bchs expression profiles:
While bchs's loss-of-function (LOF) phenotypes make it an interesting model to study progressive neural degeneration, the subtlety and timing of its adult defects has prevented the efficient design of genetic screens to clarify bchs's functional pathway or to identify potential interacting partners (FINLEY et al. 2003) . We therefore characterized a P-element insertion located in bchs (EP(2L)2299) that could be used to design a dominant gain-of-function genetic modifier screen. Previously we had mapped and sequenced the entire genomic region and cDNA sequence of the bchs gene and carried out a P-element mutagenesis screen based on excision of the EP(2L)2299 construct ( Figure 1b ). Molecular analysis showed that the EP(2L)2299 P-element line contains a single insertion located within the first bchs intron, upstream of the bchs open reading frame ( Figure  1b) . Using genetic crosses with a stock containing a constitutively active transposase (Δ2-3), the EP(2L)2299 P-element was excised and individual flies lacking the white+ marker were used to generate stocks and characterized for both precise and imprecise removal of the P-element. Both types of excisions were identified and characterized for bchs expression and mutant phenotypes (FINLEY et al. 2003; SIMONSEN et al. 2004) . The bchs 5 allele (Ex22) represents an imprecise excision that removes most of the first and second introns and the second and third exons, effectively eliminating the start codon of the message (Figure 1b) . Other lines representing precise excisions were identified that restore the original bchs sequence and gene structure (Figure 1b, bchs rev1 ). Western analysis of proteins made from 1-day old adult heads revealed that the bchs 5 mutation eliminates the production of Bchs, while the bchs rev1 line has normal levels of the protein ( Figure 1c , samples 1 and 2). Young EP(2L)2299 flies display a Bchs expression pattern similar to that of our previous findings (becomes absent in older animals) and further phenotypic characterization of this line indicated that it is as a hypomorphic or weak allele of bchs ( Figure 1c , sample 3) (FINLEY et al. 2003) . Crossing the EP(2L)2299 line with GMR-Gal4 flies (eye driver) produces F1 offspring that have at least a five-fold increase in the total levels of Bchs within the head (Figure 1c , samples 6 and 4). However, protein levels are substantially decreased when the EP(2L)2299,GMR-Gal4 chromosome is combined with a deletion that removes the entire bchs genomic region (thereby eliminating the wildtype Bchs expression) but remain elevated well above that of controls ( Figure 1c , sample 7, Df(2L)W12) (FINLEY et al. 2003 ).
Bchs's gain-of-function eye phenotype: We observed that overexpression of Bchs (GMRGal4,EP(2L)2299) led to a morphologically distinct external eye phenotype (Figure 2a) . When compared to wild type controls and the individual parental lines, the GMR-Gal4,EP(2L)2299 combination results in a dark eye pigmentation (similar to GMR-Gal4), a roughened eye surface texture and a slight decrease in the overall eye size. The dominant phenotype is sensitive to the dosage of Bchs as an additional copy of EP(2L)2299 and two copies of both GMR-Gal4 transgenes further exacerbates the eye phenotype. Excess Bchs in photoreceptor cells (normally expressed at much lower levels) also alters the neural projection patterns. These defects can be visualized by coexpressing bchs with a membrane-targeted-GFP (UAS-GFP-CAAX) (FINLEY et al. 1998) . Wild type eye discs (3 rd instar larvae) display the classic ommatidial organization for this point in retinal development ( Figure 2b ). In contrast, GMR-Gal4,EP(2L)2299 eye discs have a slight loss in morphology and a decrease in the brightness of central ommatidial region (Figure 2c , arrows), which marks the confluence of photoreceptor axons before exiting the eye disc.
The innervation patterns of R7 and R8 photoreceptors into the optic lobes can also be visualized in mid-pupal control and Bchs overexpressing animals. Wild type pupae demonstrate the normal stereotypic array of R7 and R8 projections, as well as normal axonal and growth cone morphology for this development stage ( Figure 2b ) (DITCH et al. 2005; FINLEY et al. 1998 ). In the Bchs overexpressing flies the number and basic array of R7 and R8 axonal projections remain relatively normal (Figure 2c ). However, there is a loss of growth cone morphology as well as axonal swelling or varicosities. At higher magnification, control flies show normal axonal projection patterns ( Figure 2B , arrow) and growth cone morphology (GC), while Bchs overexpression results in the loss of growth cone definition and premature termination of developing synapses. These axons also show the formation of varicosities (Figure 2c , arrows). The R7 and R8 terminal synapses are also abnormal and the Bchs protein can be detected near areas of axonal distension (Figure 2d , arrows). These findings are similar to previous studies showing that excess Bchs results in synaptic defects and the formation of axonal bulges in both larval motor neurons (KRAUT et al. 2001 ) and in photoreceptors (KHODOSH et al. 2006) .
Increased Bchs expression in neural projections results in the formation of varicosities containing ubiquitin-immunopositive inclusions or vesicles (Figure 2e , arrows), which are not detected in wildtype axons (data not shown). Flies with mutations in the bchs gene display a similar phenotype in which ubiquitinated protein profiles are altered in adult neural tissues (FINLEY et al. 2003; SIMONSEN et al. 2004 ). This suggests that either a decrease or over-production of Bchs can result in the altered accumulation ubiquitinated proteins (UB-proteins). To quantitatively examine this Western analysis was preformed on protein extracts prepared from heads taken from 1-day old control flies (Canton-S), homozygous bchs 4 mutants (EP(2)2299), bchs overexpressing animals (GMR-Gal4,EP(2)2299) as well as flies expression the dissatisfaction (dsf) gene (GMR-Gal4/UASdsf) (Figure 3a ) (PITMAN et al. 2002) . Although it is a remote possibility the EP(2)2299 P-element could potentially increased the expression of a gene located distal to bchs. Therefore Dsf overexpressing flies (GMR-Gal4/UAS-dsf) were selected as a control since the endogenous dsf gene is located distal to bchs and is the only other gene in the correct orientation for activated by the EP(2)2299 P-element. In young EP(2)2299 flies UB-proteins are elevated when compared to controls, which is consistent with our previous results showing that loss of bchs alters protein profiles (FINLEY et al. 2003) . In flies overexpressing bchs (GMR-Gal4,EP(2)2299) a significant increase is also seen in the accumulation of high molecular weight UB-proteins. In contrast, driving dsf expression in the eye (GMR-Gal4,UAS-dsf) does not alter UB-protein levels (Figure 3a ) (PITMAN et al. 2002) . This demonstrates that functional loss and over-production of bchs both result in the accumulation of UB-proteins in neural tissues. In addition, this data shows that while activation of UAS-dsf transgene produces extensive defects in eye development, these defects are distinct from those produced by excess Bchs (PITMAN et al. 2002) . These data indicate that transcriptional activation by the EP(2)2299 UAS-P-element results in an increase in only bchs expression and produces a gene-specific eye phenotype.
The easy to score dominant eye phenotype from Bchs overexpression provided an opportunity to develop an effective modifier screen.
Dominant modifier screens using overexpression of a specific protein have been employed to characterize several diverse genetic pathways including those associated with RAS/MAPK signaling (i.e. GMR-yan act or Sev-yan act ) as well as Armadillo and Notch functions (GREAVES et al. 1999; REBAY et al. 2000; VERHEYEN et al. 1996) . These types of modifier screens have been used successfully to identify factors that alter polyglutamine aggregation and mutant tau-toxicity (FERNANDEZ-FUNEZ et al. 2000; KAZEMI-ESFARJANI and BENZER 2000; SHULMAN and FEANY 2003) . In the case of Bchs, excessive levels of the protein may deplete interacting co-factors resulting in the formation of incomplete protein complexes that block axonal transport or prevent the formation or targeting of vesicle subtypes. Eye phenotypes similar to Bchs are observed when SNAP1 (a protein involved with vesicle fusion) is expressed using the same GMR-Gal4 driver (BABCOCK et al. 2004) . UAS-SNAP1 expression in motor neurons disrupts the formation of neuromuscular junctions and in the eye produces a mild rough eye phenotype that is further exacerbated with higher levels of the protein (BABCOCK et al. 2004) . Furthermore, UAS-SNAP1 expressed in combination with mutant alleles of interacting partners (dNSF2 155 and syx
Δ229
) enhances the eye phenotype (included changes to pigmentation, surface texture and the overall size of the eye), while co-expression of wild type UAS-dNSF1 or UAS-NSF2 suppresses these defects (BABCOCK et al. 2004 ). Therefore we used overexpression of Bchs in the eye to design of a gain-of-function (GOF) screen. Similar to the previous study by Khodosh et al. we initially examined a set of chromosomal deletion lines but then primarily focused on individual recessive loss-of-function mutations in a wide range of genes involved with protein turnover, vesicle trafficking or lysosomal development or function.
Bchs gain-of-function modifier screen: The similarity between the EP(2L)2299 and the UAS-SNAP1 overexpression eye phenotypes indicated that a modifier screen could be used to detect Bchs interactions using a dominant gain-of-function (GOF) eye phenotype. For this screen the GMR-Gal4,EP(2L)2299/CyO:TM6B stock line was established and used for individual crosses to mutant lines. Due to the use of the GAL/UAS system to produce elevated levels of a very large protein (with potentially complex interactions) we were concerned that co-expressing additional proteins could led to a large number of false positives. Therefore, we primarily examined lines that represented recessive loss-of-function mutations and focused on identifying genetic interactions that enhanced the eye phenotype. This design had the advantage of allowing lethal deletions or mutants to be examined. The GMR-Gal4,EP(2L)2299 stock was initially crossed to lines from the second and third Chromosome Deficiency Kits (Bloomington Stock Center). These results are included in Tables 1 and 2 in supplemental data section. Most lines do not significantly alter the eye phenotype and those lines that do behaved as enhancers. This initial screen implied that a wide range of genes did not behave as significant modifiers of the GMR-Gal4,EP(2L)2299 phenotype.
Additional lines were screened that represent recessive loss-of-function mutations in specific genes. Initially, mutant lines were selected if their genomic location overlapped with deletion chromosomes that behaved as modifiers. Subsequent lines were chosen that represented divergent cellular pathways affecting lysosomal/endosomal trafficking, neural function or development, synaptic vesicle transport or fusion, adult lifespan and cellular metabolism. Later, several UASlines that affected autophagy gene expression were also included. In all cases F1 progeny were scored for changes in adult eye size, shape, pigmentation and surface texture. Again, most genetic combinations with GMR-Gal4,EP(2L)2299 did not significantly modify the eye phenotype, indicating a degree of specificity in the detection of potential bchs genetic interactions. These results are outlined in Table 3 included in the supplemental data section. Examples of genetic mutations that did behave as modifiers of the Bchs GOF phenotype are illustrated in Figure 3 and are further detailed in Table 1 (individual lines and mutation type). To control for phenotypes resulting from dominant or non-specific interactions with the GMR-Gal4 driver, lines that were scored as modifiers were crossing individually to the GMR-Gal4 driver and the F1 offspring independently examined for eye morphology changes. Individual modifier genes that also demonstrated a phenotypic change with a corresponding deletion chromosome from the 2 nd and 3 rd Deficiency Kit screen are noted in Table 1 . Of the 20 individual 2 nd or 3 rd chromosome mutations identified as modifiers, a total of 6 showed an eye phenotype that was similar to the overlapping deletion allele. Significant changes to eye phenotypes were not observed when the GMR-Gal4 driver was used to overexpress independently several other autophagy genes (individual EP-UAS lines) or in combination recessive loss-of-function mutations (results are shown in Figure 1 located in the supplemental data section).
Modifying autophagy genes: Of the six Drosophila autophagy genes examined in this study, mutations in Atg1 (serine/threonine kinase) and Atg6 (Beclin-1) were scored as moderate eye enhancers, while functional loss of the Atg18 gene (PtdIns(3,5)P 2 binding protein) only had a minor effect (Figure 3b, 3c, 3d) . In contrast, co-expression of atg2 (EP-UAS line) atg8a (EP-UAS line) moderately suppressed the Bchs-GOF phenotype (Figure 3e, 3f) (KOUNO et al. 2005) . Atg8/LC3 remains bound to autophagic membranes until degradation in lysosomes, thus serving as a useful marker of autophagy (OHSUMI 2001) . In yeast and flies, Atg1 is required for autophagosome biogenesis and is found on pre-autophagic and autophagic double membrane structures together with Atg18 (REGGIORI et al. 2004; SCOTT et al. 2004) . Mutations in both Drosophila atg1 and atg18 have been shown to block starvation-induced autophagy in larval fat body tissue (SCOTT et al. 2004 ). For our assay, enhancement of the dominant eye phenotype likely indicates that a decreased level of key autophagy components in conjunction with excess Bchs exacerbate the GOF eye defects. At this time the cellular mechanism of this enhancement is unclear but may involve defects with autophagic vesicle formation or global perturbation of microtubule-mediated transport of membrane vesicles.
Modifying mutations in AP-3 complex and late endosomal genes: Although endogenous Bchs is not expressed in pigment cells and functional loss of Bchs does not alter pigment granule formation (data not shown) mutations that affect eye and body pigmentation were examined because pigment vesicles or granules originate as part of the lysosomal biogenesis pathway. Several genes involved with lysosomal and pigment granule biogenesis acted as strong Bchs-GOF modifiers. They include the four subunits of the Drosophila AP-3 adaptor complex, which mediate trafficking between the trans-Golgi network and lysosomes (BOEHM and BONIFACINO 2002) . Mutations in orange (ξ-subunit, Figure 3g ) and ruby (β-subunit, Figure 3h ) are strong enhancers while alterations to garnet (δ-subunit, Figure 3i ) and carmine (µ-subunit, Figure 3j ) behave as complex modifiers by enhancing pigmentation defects and suppressing the eye size reduction (LLOYD et al. 1998) . A decrease in pigmentation suggests that expression of Bchs in pigment cells (where it is normally not expressed) has a deleterious effect on pigment granule formation.
Spinster mutations also behave as enhancers of the Bchs-GOF eye phenotype (Figure 3k ). Encoding an integral membrane protein, hypomophic spinster alleles were first identified having adult behavior and neural development defects (NAKANO et al. 2001) . More recently, spinster (benchwarmer) mutants demonstrate neural degeneration accompanied by the formation of late endosomal inclusions (DERMAUT et al. 2005) . Localized to lysosomes and late endosomes the vertebrate spinster protein promotes the autophagic cell death pathway in cultured cells (YANAGISAWA et al. 2003) . Mutations in other genes classified with late endosomal/lysosomal functions also act as Bchs-GOF enhancers. They include deep orange (dor, Vps18p, E3-ligase, Figure 3l ) and carnation (Vps33, sec1 protein, Figure 3m ) (SEVRIOUKOV et al. 1999) . These proteins are members of the HOPS trafficking complex (homeotypic vacuole fusion and protein sorting) and in Drosophila are known to promote late endosomal/lysosomal fusion events (SRIRAM et al. 2003) . Recently we have demonstrated that, like its yeast homologue Vps18p, Drosophila dor is required for autophagosome-to-lysosome fusion during programmed autophagy in the larval fat body (LINDMO et al. 2006) . Mutant alleles of a second Sec1 protein, ras opposite (rop, munc-18/nSec1) enhance the Bchs-GOF phenotype (Figure 3n ) as do mutant alleles of syntaxin1A, syntaxin13 and the coiled-coil protein hook (Figure 3o, 3p) Figure 3q ) (NARAYANAN et al. 2000) . Both hook and dor proteins are found in larval neuromuscular synapses and mutations in both alter synaptic size and number (increased in hook and decreased in dor) (NARAYANAN et al. 2000) . Ras opposite, syntaxin1A and syntaxin 13 are SNARE proteins that are involved in neurotransmitter release (CIUFO et al. 2005) .
Another important class of proteins involved in regulating vesicle trafficking and fusion is Rab GTPases. Several independent mutations in Rab11 (Figure 3r ) act as very strong enhancers of the Bchs-GOF phenotype. Rab11 is known to associate with multiple vesicle subtypes ranging from recycling endosomes to trans-Golgi vesicles and has important roles in endocytosis (recycling and lysosomal targeting) and membrane targeting during cytokinesis and cellularization (PELISSIER et al. 2003) . The potential genetic interaction between Rab11 and Bchs was recently confirmed in a similar study that examined their combinatorial effect on synaptic development and morphogenesis (Khodosh et. al 2006) . In the Drosophila eye, Rab11 also mediates rhodopsin exocytosis and prevents photoreceptor degeneration (SATOH et al. 2005) . Additional genes involved with the biogenesis of lysosomes and related organelles were also identified as having potential interactions with Bchs. They include a second rab gene, lightoid (Figure 3s ) and claret, a GTPases guanine nucleotide exchange factor (Figure 3t ) (MA et al. 2004 ). These two proteins are known to interact and promote the formation of pigment granules during eye development (MA et al. 2004) .
Cytoskeletal/motor proteins and ubiquitin/SUMO pathway members modifiers: Recent studies examining the removal of aggregate-prone proteins revealed that microtubules and motor proteins are required for appropriate formation and trafficking of autophagosomes (KAMAL and GOLDSTEIN 2000; RAVIKUMAR et al. 2005) and point mutations in human dynein results in an ALS-like form of neuronal degeneration. Since Bchs contains potential motifs implicated in interactions with motor and cytoskeleton proteins we therefore assayed mutations in this class of genes. The Bchs-GOF phenotype was significantly enhanced by mutations in the dynein light chain (DLC, Figure 3u ) and α-tubulin (Figure 3w ) genes and to a lesser extent with the dynein heavy chain gene (DHC, Figure 3v ) (FLYBASE.BIO.INDIANA.EDU 2007). β-tubulin mutations did not show a significant change in the overall Bchs-GOF phenotype (Figure 3x ) as do other functionally related genes (i.e. actin). Since bchs mutant flies demonstrate age-related changes to CNS ubiquitinated protein profiles, genes in the ubiquitin and SUMO signaling pathways were also assayed (FINLEY et al. 2003) . While its unknown if Bchs directly interacts with ubiquitin or SUMO, ubiquitin/SUMO signaling has profound effects on vesicle specification and trafficking to lysosomes and both can be major constituents of cellular inclusions (CIECHANOVER 2005; STEFFAN et al. 2004) . Mutant alleles of the Drosophila SUMO gene (smt3, Figure 3y ) enhances the Bchs-GOF phenotype as do mutations in the SUMO conjugating enzyme lesswright (lwr, Figure 3z) Figure 3aa ), a C-terminal ubiquitin hydrolase (CG1490, Figure 3bb ) and effete (UbcD1, Ubiquitin conjugating enzyme 1, Figure 3cc ) also are Bchs-GOF enhancers (OHLMEYER and SCHUPBACH 2003) .
Adult lifespan profiles of Bchs modifiers:
A key phenotype associated with functional loss of bchs in adult Drosophila is a significant reduction in longevity. We therefore asked if genes with potential genetic interactions with bchs demonstrate a similar LOF phenotype. To test this hypothesis, we examined the lifespan of mutations that were identified by the Bchs modifier screen. Fortunately, several mutant alleles exist that produce homozygous viable adults with normal appearance and activity levels. To control for genetic background effects related to lifespan, mutant lines were first out-crossed for several generations to wild type stocks (Canton-S or w 1118 ) and independent lines reestablished for these studies. The hook 1 and hook 11 lines were assayed independently from each other and in heterozygous combination (hook 1 /hook 11 ). Newly emerged adults were collected and aged to determine the lifespan profiles for deep orange, light, carnation, hook, ruby, garnet, carmine and atg8a mutants at both 25°C and 29°C (Figure 5a and 5b) . The results are summarized in Table 2 The mutants that demonstrated the shortest average lifespan were weak alleles of deep orange and a P-element insertion allele of atg8a (Figure 5a) (KRAMER and PHISTRY 1996) and this study shows that hook 1 and hook 1 /hook 11 transheterozygous flies have decreased longevity profiles similar to bchs adults (Table 2) . Several mutant lines have average lifespans greater than bchs mutants, but still significantly less than control lines. At 25°C they include light, carmine, ruby and garnet mutations, as well as a Pelement insertion into the atg8a gene (Figure 5a ). Most mutants have similar profiles when compared at 25°C and 29°C. The exceptions are rosy 26 , which has a significant decrease in longevity at 29°C, and garnet 1 mutants that have a nearly normal lifespan (Figure 5b ). While these lysosomal trafficking mutants have been studied extensively in terms of synaptic vesicle function and pigment granule development, to our knowledge this is the first detailed examination of their lifespan profiles. Our results clearly show that mutations in lysosomal trafficking proteins can reduce adult longevity.
To determine if mutations in bchs and other lysosomal trafficking genes have an additive effect on adult phenotypes we established crosses between different allelic combination of bchs and other lysosomal trafficking mutants. Unfortunately, the combination of strong deletion alleles of bchs (Df(2L)dsf3/Df(2L)clot7 or Df(2L)dsf3/Df(2)w3) with several lysosomal genes produced very few double mutant adults (FINLEY et al. 2003; FINLEY et al. 1998 5 /Df(2L)dsf3 genetic combinations were substantially reduced but a few viable flies were produced. Heads were harvested from 1 to 2 day old animals and protein extracts examined by Western blot analysis. Since bchs LOF mutations do not produce an easy to score phenotype we confirmed functional loss of bchs by Western analysis (anti-Bchs) in conjunction with total UB-protein profiles (Figure 3b) . As seen previously, bchs mutants (bchs5/Df(2L)dsf3) have an elevated UB-protein level when compared to age-matched controls (Canton-S). A similar elevation in large UB-proteins was also detected for ruby 1 
DISCUSSION
Lysosomal-autophagic trafficking defects:
There is growing evidence that defects in lysosomal transport or clearance of age-related or disease-associated proteins can play a central role in the etiology of many neural degenerative disorders (CATALDO et al. 1996; GARCIA-MATA et al. 2002; RAVIKUMAR et al. 2005; YU et al. 2005) . Previous work on Bchs and Alfy indicated that these proteins are involved with the autophagic clearance of ubiquitinated substrates. Human Alfy co-localizes with cytoplasmic ubiquitin structures and autophagic membranes and older bchs mutant flies accumulate ubiquitinated CNS aggregates (FINLEY et al. 2003; SIMONSEN et al. 2004) . In this study we show that high levels of Bchs in the Drosophila eye cause a dominant eye phenotype in which external eye structures and neural development are perturbed (Figure 2 ). Neural defects include alterations to the formation of terminal synapses and axonal varicosities containing ubiquitin. Biochemical analysis reveals that both bchs mutant and overexpressing flies show similar changes in UB-protein profiles (Figure 1 ). These phenotypes suggest that lysosomal transport defects alter the turnover of UB-proteins (GUNAWARDENA and GOLDSTEIN 2001; NIXON et al. 2005) . A Bchs-GOF screen was designed around this overexpression eye phenotype and used to identify several candidate proteins (modifiers) that potentially have genetic interactions with Bchs.
The role of lysosomal mutations in adult viability: Several loss-of-function mutations within the autophagic pathway were found to behave as Bchs-GOF enhancers (Atg1 and Atg6), while two transgenic lines that allow GMR-Gal4 driven co-expression with EP(2L)2299 (UAS-atg2 and UAS-atg8a) mildly suppress a dominant eye phenotype. This is similar to previous findings with GMR-Gal4 expression of UAS-SNAP in which the genetic background of known interacting factors enhanced or suppressed the dominant eye phenotype (BABCOCK et al. 2004) . Other classes of proteins that are involved with different aspects of lysosomal transport also act as Bchs-GOF modifiers, including the four subunits of the AP-3 protein complex (orange, ruby, garnet and carmine). These four protein subunits have primarily been characterized in terms of pigment granule biosynthesis but clearly they have additional cellular functions since all are located within Drosophila nerve terminals and have a subtle role on adult behaviors (BOEHM and BONIFACINO 2002; DELL'ANGELICA et al. 2000) . Lysosomal trafficking and pigmentation defects are also observed with mutant mammalian AP-3 homologues. Mutant mocha (δ-subunit) and pearl (β3A-subunit) mice have pigmentation defects and lysosomal abnormalities as do humans suffering from Hermansky-Pudlak syndrome (β3A-subunit) (BOEHM and BONIFACINO 2002; DELL'ANGELICA et al. 2000) . In addition mocha mice demonstrate progressive inner ear and neurological degeneration.
Several proteins characterized as having roles in the late endosomal pathway were scored as positive Bchs-GOF eye modifiers including mutations in the spinster, hook, deep orange and carnation genes. Drosophila mutations in these genes have been shown to affect neuronal maintenance and degeneration. Defects in the mouse and human homologues of carnation (Vps33) generate buff mutant mice and the ARC syndrome in humans (Vps33B, lethal multi-system disorder) respectively (GISSEN et al. 2004 ). Previously we have shown that, in addition to the late endosomal-lysosomal fusion events, the Deep orange protein also facilitates the formation of autolysosmes (autophagosome-lysosome vesicles) or amphisomes (autophagosome-late endosome vesicles) (LINDMO et al. 2006; RIEDER and EMR 1997) . Other known "lysosomal" proteins that mediate a host of trafficking/fusion events in several vesicle-subtypes were also scored as Bchs-GOF modifiers. These include ras opposite, syntaxin1A, syntaxin13, Rab11, lightoid, claret, α-tubulin and the dynein light chain mutations. Defects in dynein-mediated transport are linked with neurodegenerative disorders and recently shown to impair autophagy-mediated clearance of neuronal protein aggregates (RAVIKUMAR et al. 2005) .
The addition of ubiquitin to protein substrates is used by the cell as a signal for proteasome degradation or as a sorting signal for endocytotic trafficking to the lysosome. The accumulation of ubiquitated-protein aggregates or inclusions is a key feature of many neural degenerative disorders and is a primary phenotype associated with bchs loss-of-function mutations. More recently SUMOylated proteins have also been found in neural inclusions, indicating that multiple changes in protein modification, trafficking and/or proteolytic turnover pathways can be a central feature of neural degeneration and reduced viability (STEFFAN et al. 2004 ). In our study mutations in both the SUMO (SUMO and lesswrite) and ubiquitin (uba, CG1490 and effete) pathways behaved as enhancers of the Bchs-GOF phenotype. At this time it remains unclear if this is due to direct interactions between the Bchs protein and ubiqutinated or SUMOylated substrates or to a general blockage in vesicle sorting and transport.
Deletion lines and negative modifiers indicate screen selectivity: In this study we identified eight regional deletions that behave as Bchs-modifiers, which removed individual genes that were also scored as modifiers (Table 1, bolded) . The remaining eleven Bchs-modifier genes located on the 2 nd and 3 rd chromosome were eliminated by a deletion interval that did not generate a phenotype meeting the criteria set as being sufficiently significant. This discrepancy may be related to the level of modification produced by an individual mutation. In our screen and in a separate study (KHODOSH et al. 2006 ) Rab11 mutations show a pronounced unambiguous eye phenotype that corresponds well with regional deletions. A similar strong phenotype was also seen with the lightoid mutations (Fig. 4S) were both a single mutation or elimination of its genomic region resulted in obvious modification of eye. This implies that an intermediate phenotype may be masked by the removal of other genes in the region that act as even moderate suppressors. A moderate suppression could involve the loss of a direct interaction between a trafficking protein and Bchs or the removal of transcription factors that normally enhance the endogenous bchs gene expression or have an upstream affect on the Gal4/UAS driven expression. Although the deletion screen was informative the direct testing individual of genes helped to more quickly narrow the focus of this study.
Information regarding Bchs's functional pathway was also obtained from mutations that had little or no effect on the dominant Bchs-GOF eye phenotype. For a complete list of mutations that were tested and determined not to modify the Bchs eye phenotype see Table 3 in supplemental data section. Eye-pigment mutants that are members of the ABC transporter class of lysosomal proteins (white, brown and scarlet) did not modify the Bchs-GOF phenotype nor did genes that have early endosomal functions like hrs, clatherin-HC or lap (AP180-like protein) (FLYBASE. BIO.INDIANA.EDU 2007) . Additional genes in vesicle trafficking pathways were also tested and mutations in sec61α, synaptotagmin, doa, rph, rab5 and rab14 genes did not produce significant modification of the Bchs eye phenotype (data not shown) (FLYBASE. BIO.INDIANA.EDU 2007) . Since insulin/TOR signaling is known to regulate autophagy, members of this pathway were examined for Bchs interactions (KAPAHI et al. 2004; RAVIKUMAR et al. 2004) . Mutations in chico (insulin-like receptor), InR and Tor genes did not have a significant effect on the Bchs-GOF phenotype (KAPAHI et al. 2004) . This may indicate a lack of direct protein interactions with Bchs or that a second signaling pathway regulates different features of autophagy regarding aggregate clearance in neurons. Kinesin motor proteins play a major role in vesicle trafficking and several mutations in kinesin and kinesin-like genes were examined and none produced a significant change in the Bchs-GOF phenotype. Finally, not all members of the ubiquitin-signaling pathway acted as Bchs-modifiers, including mutations in Ubp64E, Uch-L3, fat facets, UbcD 10 and UbcD4. The fact that only certain genes in lysosomal trafficking pathways acted as Bchs-GOF modifiers highlights the interaction specificity of the screen's design. It also indicates that Bchs may preferentially interact with proteins involved in late transport events to the lysosome, autophagic-to-lysosomal or trans-Golgi/late endosomal-tolysosomal transport processes.
Decreased longevity and UB-protein accumulation in lysosomal trafficking mutants: Lysosomal trafficking defects are often associated with progressive disorders and reduced viability (BRUNK and TERMAN 2002; CATALDO et al. 1996; CUERVO 2004; DELL'ANGELICA et al. 2000) . To further clarify the role that lysosomal transport has on the adult Drosophila lifespan, mutant lines identified from the modifier screen were examined for changes in adult longevity. We found that mutations in several AP-3 genes (ruby, garnet and carmine), late endosomal pathway genes (i.e. deep orange, carnation and hook) and the autophagy gene atg8a, resulted in reduced average adult lifespans. While the decrease in longevity associated with bchs mutations can be attributed to progressive neural defects this may not be the case for mutations in other lysosomal import genes. Bchs is primarily expressed in neurons while the other genes have a broader expression pattern (FINLEY et al. 2003) . For example we have shown that dor (described as an endosomal gene) is required for programmed autophagy in larval fat body cells (LINDMO et al. 2006) . This suggests that lysosomal defects in non-neuronal tissues may also contribute to premature adult death associated with these mutants (LINDMO et al. 2006) . However, a preliminary examination of UBproteins from mutant flies show that most genotypes demonstrate a pronounced accumulation of proteins. In addition, several double mutant combinations with bchs show an additive effect on UBprotein levels, with the most striking effect occurring with dor 1 and carnation 1 mutations. While both proteins are known to genetically interact and closely associate during late endosomal trafficking we have recently shown that the Dor protein functions during the activation of the programmed autophagic pathway in the larval fat body. The implications are that individual proteins may have dual functions, which reflect tissue-specific or age-dependent requirements coming from different lysosomal trafficking pathways.
Conclusion:
The genetic analysis of bchs interactions further supports the hypothesis that Bchs serves as a large scaffolding protein with multiple interacting partners. These genetic interactions primarily involve genes known to promote the transport, targeting or fusion of different vesicle sub-populations with the lysosome. Viable loss-of-function mutations in autophagic, transGolgi and late endosomal pathway members produce subtle but progressive defects that decrease adult longevity by altering the transport of substrates to the lysosome. Furthermore, our Drosophila genetic findings have implications for human disease since each gene characterized in this study has a direct human homologue and several are associated with diseases characterized by defects in lysosomal trafficking or function (FLYBASE. BIO.INDIANA.EDU 2007) . Many others have not been directly linked to a human disease but several map to loci associated with progressive disorders. Using Drosophila as an efficient model system, these genes and phenotypic defects can become a focus for future studies related to human disorders. *Standard deviation from the mean. ** P values were calculated using Canton-S as a control. Figure 1 . __ Functiontional motifs of Bchs/Alfy, mutant alleles and protein profiles. (a) Members of the bchs/Alfy gene family encode very large, highly conserved proteins with several potential functional protein domains. The C-terminus contains a FYVE finger motif (binds PtdIns(3)P lipids), a BEACH domain and a series of WD40 repeats (protein-protein interaction domain). The remaining N-terminal ~2000 amino acids of the Bchs and Alfy proteins are also highly conserved and leucine-isoleucine rich. Motif-modeling programs predict several leucinebased motifs including leucine zippers and coiled-coil domains, which primarily facilitate protein interactions and dimerization.
FIGURE LEGENDS
Further sequence analysis identifies a second potential phosphatidylinositol interaction motif (PH domain). Sequence analysis of the Bchs/Alfy family indicates these proteins likely facilitate a diverse series of protein interactions as well having close associations with membrane vesicles. (b) The insertion site of the EP(2L)2299 transposable element is located in the first intron of bchs and allows Gal4-driven expression of the full-length Bchs protein. The Df(2L)w12 deletion was characterized during our the initial characterization and mapping of the bchs and dsf genes and removes nearly 60 kb of genomic sequence containing both genes. Several lines were also isolated that represent individual P-element excisions that generate micro-excision alleles of bchs (Ex22 or bchs 5 ) or fully restore the gene (bchs rev1 ). (c) Western analysis of protein extracts made from adult heads shows that Bchs is a large protein (>250 KD) that is absent from bchs 5 mutants (#1) and is expressed at normal levels in bchs rev1 animals (#2). Young homozygous EP(2L)2299 flies (#3) produce Bchs at levels that are similar to Canton-S (#4) and w 1118 (#5) control animals. The Bchs protein is increased five-fold when overexpressed in EP(2L)2299,GMR-Gal4 flies (#6) above that of Canton-S flies (#4). Using a small deletion that eliminates one bchs allele reduces the total level of Bchs even when it is overexpressed in the eye (EP(2L)2299,GMR-Gal4/Df(2L)W12) (#7). __ Bchs eye modifiers. Fly eyes representing one copy of the GMR-Gal4, EP(2L)2299 expression transgenes in (a) wild type control (Canton-S) or in heterozygous mutant backgrounds. Mutations in autophagy genes (b) atg1 and (c) atg6 enhance the eye phenotype while (d) a P-element mutation in atg18 has only a slight effect on the Bcsh-GOF phenotype. Coexpression of (e) UAS-atg2 and (f) UAS-atg8a were scored as phenotype suppressors. Mutations in (g) orange (or, adaptor complex AP-3 ξ-subunit) act as phenotype enhancers, while mutations in (h) ruby (rb, AP-3 β-subunit), (i) garnet (g, AP-3 δ-subunit) and (j) carmine (cm, AP-3 µ-subunit) are complex modifiers. Mutations in other vesicle trafficking genes including (k) spinster (spin), (l) deep orange (dor), (m) carnation (car), (n) ras opposite (rop), (o) syntaxin1A (syx1A), (p) syntaxin13 (syn13), (q) hook (hk), (r) rab-protein 11 (Rab11), (s) lightoid (ltd), and (t) claret (ca) all act as strong Bchs-GOF enhancers. Other proteins involved in lysosomal transport are also Bchs enhancers and include mutations in the (u) dyneinLC and (w) α-tubulin genes and to a much lesser extent (v) dyneinHC and (x) β-tubulin mutations. Mutations in SUMO and ubiquitin pathway members are Bchs-GOF enhancers and include (y) SUMO, (z) lesswright (lwr), (aa) Uba1, (bb) Cterminal ubiquitin hydrolase (CG1490) and (cc) effete mutations. (dd) The GMR-Gal4, EP(2L)2299 transgenes in a white 1118 background are shown as a non-modifying negative control.
Figure 5.
__ Lifespan profiles of Bchs modifiers. Newly eclosed males from different genotypes were collected and aged at (a) 25°C and (b) 29°C for the duration of the experiment. The percentage of individuals for a given genotype that had survived for a given day is calculated from the total number of flies. For each genotype the total number of flies (n) used in the experiment, their mean lifespans, standard deviations and p values are summarized in Tables 2a and 2b. 
